Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors—correlation to tumor histopathology and clinical follow-up

[1] Ragnhammar P(2001)A systematic overview of chemotherapy effects in colorectal cancer Acta Oncol 40 282-308

[2] Hafström L(2001)Determinants of prognosis and response to therapy in colorectal cancer Curr Oncol Rep 3 102-108

[3] Nygren P(2001)Adjuvant chemotherapy for colon cancer Curr Oncol Rep 3 94-101

[4] Glimenius B(2000)The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil Pharmacology 61 199-203

[5] Iqbal S(1992)Angiogenic factor Nature 356 668-14

[6] Lenz HJ(1993)Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor J Biochem (Tokyo) 114 9-1117

[7] Kumar SK(1996)Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma J Natl Cancer Inst 88 1110-693

[8] Goldberg RM(1997)Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy Br J Cancer 76 689-2376

[9] Diasio RB(1998)High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil Clin Cancer Res 4 2371-1327

[10] Johnson MR(2000)Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase Clin Cancer Res 6 1322-198

[1] Ragnhammar P(2001)A systematic overview of chemotherapy effects in colorectal cancer Acta Oncol 40 282-308

[2] Hafström L(2001)Determinants of prognosis and response to therapy in colorectal cancer Curr Oncol Rep 3 102-108

[3] Nygren P(2001)Adjuvant chemotherapy for colon cancer Curr Oncol Rep 3 94-101

[4] Glimenius B(2000)The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil Pharmacology 61 199-203

[5] Iqbal S(1992)Angiogenic factor Nature 356 668-14

[6] Lenz HJ(1993)Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor J Biochem (Tokyo) 114 9-1117

[7] Kumar SK(1996)Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma J Natl Cancer Inst 88 1110-693

[8] Goldberg RM(1997)Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy Br J Cancer 76 689-2376

[9] Diasio RB(1998)High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil Clin Cancer Res 4 2371-1327

[10] Johnson MR(2000)Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase Clin Cancer Res 6 1322-198